Blood test may predict deadly transplant complication
NCT ID NCT07508345
First seen Apr 08, 2026 · Last updated Jun 16, 2026 · Updated 11 times
Summary
This study tested whether counting certain cells in the blood before a stem cell transplant can predict the risk of acute graft-versus-host disease (GVHD), a serious complication. Researchers enrolled 50 adults receiving their first transplant for blood cancer. The goal was to see if this simple blood test could help identify high-risk patients early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GVHD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fondazione IRCCS Policlinico San Matteo di Pavia
Pavia, Pavia, 27100, Italy
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.